Eleven finalists have been announced for the $2.25 million Nokia Sensing XChallenge, a global competition to develop breakthrough medical-sensing technologies that will ultimately enable faster diagnoses and easier personal health monitoring. An online voting campaign is now open to the general public at www.nokiasensingxchallengevoting.org through Oct. 30, 2014. The votes will account for 10% of the finalist teams' overall scores, with the remainder based on evaluations by a panel of digital health and medical industry experts. Videos of the breakthrough technologies can be viewed on the site.
And the finalists are:
• Archimej Technology (Evry, France), a startup led by co-founder Francisco Vega, developing technology focused on making blood analysis available remotely at an affordable price.
• Atoptix (State College, PA), a team of electrical engineering professors at Pennsylvania State University, led by co-founder Perry Edwards, PhD, focusing on mobile-based sensing of blood and tissue to assess personal health information.
• Biovotion (Zürich, Switzerland), a team led by founder and CEO Andreas Caduff, PhD, developing a wearable multisensor concept for monitoring patients with chronic conditions.
• DMI (Cambridge, MA), also a finalist team for the $10M Qualcomm Tricorder XPRIZE and led by Eugene Y. Chan, MD, CEO, and Head Scientist at the DNA Medicine Institute, designing a sensor that will assess hundreds of clinical lab tests via a single drop of blood.